Pfizer The Riser: How Investors Yielded 1022% Returns

If you had invested ₹1 lakh in Pfizer in November 2002, you could have had ₹13.88 lakhs in profits today! This multibagger gave its investors 1022% returns in 20 years. Let’s have a peek at the company.

💊 Stock Name: Pfizer Ltd.
💊 NSE: $PFIZER

⭐ About The Company
Established in India in the year 1950 and a subsidiary of Pfixer Inc., Pfizer Limited is the 3rd largest pharmaceutical manufacturer and retailer in India, producing pharma products in-house and through independent distributors. Pfizer entered the Indian domain through Dumex, setting up its first production unit in Darukhana, Mumbai. It was the first company in the country to conduct clinical research.

🐄 Cash Cow
Earning a revenue of ₹2000 crores, Pfizer India’s top business division is pharmaceutical product manufacturing and retailing. The pharma giant is responsible for popular brands like Benadryl, Corex, Gelusil and more.

Animal pharmaceuticals is another speciality of the healthcare giant and it is among the top 4 players in the Indian market. Undertaking clinical trials on a global level, the R&D division of Pfizer India has defined the research culture in India.

🌍 Global Presence
Pfizer manufactures 4 billion tablets on an annual basis, catering to markets outside India in countries like Nepal, Bangladesh and Sri Lanka. Its standalone manufacturing plant in India is located in Goa.

💰 Stock Value
💵 On November 1, 2002, the shares of the company were trading at ₹389.95, while they were priced at ₹4378.05 as of October 31, 2022.